125 related articles for article (PubMed ID: 8696342)
1. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21.
Rahman N; Arbour L; Tonin P; Renshaw J; Pelletier J; Baruchel S; Pritchard-Jones K; Stratton MR; Narod SA
Nat Genet; 1996 Aug; 13(4):461-3. PubMed ID: 8696342
[TBL] [Abstract][Full Text] [Related]
2. Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2.
Rapley EA; Barfoot R; Bonaïti-Pellié C; Chompret A; Foulkes W; Perusinghe N; Reeve A; Royer-Pokora B; Schumacher V; Shelling A; Skeen J; de Tourreil S; Weirich A; Pritchard-Jones K; Stratton MR; Rahman N
Br J Cancer; 2000 Jul; 83(2):177-83. PubMed ID: 10901367
[TBL] [Abstract][Full Text] [Related]
3. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
[TBL] [Abstract][Full Text] [Related]
4. Evidence for genetic heterogeneity in familial Wilms' tumor.
Huff V; Amos CI; Douglass EC; Fisher R; Geiser CF; Krill CE; Li FP; Strong LC; McDonald JM
Cancer Res; 1997 May; 57(10):1859-62. PubMed ID: 9157975
[TBL] [Abstract][Full Text] [Related]
5. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
[TBL] [Abstract][Full Text] [Related]
6. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors.
McDonald JM; Douglass EC; Fisher R; Geiser CF; Krill CE; Strong LC; Virshup D; Huff V
Cancer Res; 1998 Apr; 58(7):1387-90. PubMed ID: 9537236
[TBL] [Abstract][Full Text] [Related]
7. Familial Wilms tumor.
Ruteshouser EC; Huff V
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):29-34. PubMed ID: 15264270
[TBL] [Abstract][Full Text] [Related]
8. Lack of linkage of familial Wilms' tumour to chromosomal band 11p13.
Huff V; Compton DA; Chao LY; Strong LC; Geiser CF; Saunders GF
Nature; 1988 Nov; 336(6197):377-8. PubMed ID: 2848200
[TBL] [Abstract][Full Text] [Related]
9. Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1.
Rahman N; Abidi F; Ford D; Arbour L; Rapley E; Tonin P; Barton D; Batcup G; Berry J; Cotter F; Davison V; Gerrard M; Gray E; Grundy R; Hanafy M; King D; Lewis I; Ridolfi Luethy A; Madlensky L; Mann J; O'Meara A; Oakhill T; Skolnick M; Strong L; Stratton MR
Hum Genet; 1998 Nov; 103(5):547-56. PubMed ID: 9860296
[TBL] [Abstract][Full Text] [Related]
10. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
Grundy P; Koufos A; Morgan K; Li FP; Meadows AT; Cavenee WK
Nature; 1988 Nov; 336(6197):374-6. PubMed ID: 2848199
[TBL] [Abstract][Full Text] [Related]
11. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
Pritchard-Jones K; Fleming S
Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
13. Case of interstitial 12q deletion in association with Wilms tumor.
Rapley EA; Hargrave D; Persinguhe N; Barfoot R; Moore I; Radford M; Stratton MR; Rahman N; Pritchard-Jones K
Am J Med Genet; 2001 Dec; 104(3):246-9. PubMed ID: 11754052
[TBL] [Abstract][Full Text] [Related]
14. Wilms' tumour as a paradigm for the relationship of cancer to development.
Pritchard-Jones K; Hastie ND
Cancer Surv; 1990; 9(3):555-78. PubMed ID: 1966278
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.
Altura RA; Valentine M; Li H; Boyett JM; Shearer P; Grundy P; Shapiro DN; Look AT
Cancer Res; 1996 Aug; 56(16):3837-41. PubMed ID: 8706032
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.
Grundy RG; Pritchard J; Scambler P; Cowell JK
Oncogene; 1998 Jul; 17(3):395-400. PubMed ID: 9690521
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
Grundy P; Telzerow P; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
[TBL] [Abstract][Full Text] [Related]
18. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
Brown KW; Power F; Moore B; Charles AK; Malik KT
Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at 7p in Wilms' tumour development.
Powlesland RM; Charles AK; Malik KT; Reynolds PA; Pires S; Boavida M; Brown KW
Br J Cancer; 2000 Jan; 82(2):323-9. PubMed ID: 10646884
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors.
Ruteshouser EC; Hendrickson BW; Colella S; Krahe R; Pinto L; Huff V
Genes Chromosomes Cancer; 2005 Jun; 43(2):172-80. PubMed ID: 15761866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
